Roche Holding AG (RHHBY) Stock Climbs on $750M PathAI Deal to Advance AI-Driven Cancer Diagnostics

Roche (RHHBY) stock rises 1.55% following announcement of PathAI acquisition for $750M, enhancing AI-powered cancer diagnostics and digital pathology capabilities.

The post Roche Holding AG (RHHBY) Stock Climbs on $750M PathAI Deal to Advance AI-Driven Cancer Diagnostics appeared first on Blockonomi.